Q Biomed Inc. (QBIO) SEC Filing 10-K Annual report for the fiscal year ending Friday, November 30, 2018

SEC Filings

Q Biomed Inc.

CIK: 1596062 Ticker: QBIO
Document and Entity Information - USD ($)
12 Months Ended
Nov. 30, 2018
Feb. 26, 2019
May 31, 2018
Document and Entity Information   
Entity Registrant NameQ BIOMED INC.  
Document Type10-K  
Document Period End DateNov. 30, 2018  
Amendment Flagfalse  
Entity Central Index Key0001596062  
Current Fiscal Year End Date--11-30  
Entity Common Stock, Shares Outstanding 14,466,155 
Entity Filer CategoryNon-accelerated Filer  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Document Fiscal Year Focus2018  
Document Fiscal Period FocusFY  
Entity Public Float  $ 34,809,642
Trading SymbolQBIO  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  

View differences made from one year to another to evaluate Q Biomed Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Q Biomed Inc..


Assess how Q Biomed Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Q Biomed Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Q Biomed Inc. provided additional information to their SEC Filing as exhibits

Ticker: QBIO
CIK: 1596062
Form Type: 10-K Annual Report
Accession Number: 0001144204-19-012723
Submitted to the SEC: Thu Mar 07 2019 1:12:08 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Friday, November 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: